Senex Biotechnology, Inc.
9Patents
9Active
9Granted
43Portfolio score
Filing activity: Jan 12, 2006 → May 25, 2021 · 2 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8598344B2 | CDKI pathway inhibitors and uses thereof | Human Necessities | 5 | Active |
| US9321737B2 | CDK8-CDK19 selective inhibitors and their use in anti-metastatic and chemopreventative methods for cancer | Physics | 5 | Active |
| US11014906B2 | Quinoline-based compounds and methods of inhibiting CDK8/19 | Chemistry; Metallurgy | 2 | Active |
| US12281080B2 | Quinoline-based compounds and methods of inhibiting CDK8/19 | Chemistry; Metallurgy | 0 | Active |
| US10993945B2 | CDK8-CDK19 selective inhibitors and their use in anti-metastatic and chemopreventative methods for cancer | Physics | 0 | Active |
| US9409873B2 | CDKI pathway inhibitors and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US10584369B2 | Cell-based methods for measuring activity of a protein inhibitor | Physics | 0 | Active |
| US8592147B2 | High-content screening for drugs against cancer and age-related diseases | Physics | 0 | Active |
| US11572369B2 | Bicyclic pyridine compositions and methods of using the same for cancer therapy | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.